Literature DB >> 12414424

Transconjunctival lower eyelid involutional entropion repair: long-term follow-up and efficacy.

Shawn J Khan1, Dale R Meyer.   

Abstract

OBJECTIVE: To evaluate the safety and long-term efficacy of a modified transconjunctival involutional lower eyelid entropion repair.
DESIGN: Retrospective, noncomparative case series and survey. PARTICIPANTS: Eighty-nine consecutive patients with involutional entropion (114 eyelids).
METHODS: Modified transconjunctival involutional lower eyelid entropion repair technique was performed on 114 eyelids of 89 consecutive patients over a 7-year period. All cases had a minimum of 3 months of initial office follow-up, with extended follow-up obtained via standardized telephone interviews. MAIN OUTCOME MEASURES: Surgical success and entropion recurrence.
RESULTS: Surgery was completed successfully with no complications in all 114 cases. All cases demonstrated correction of entropion at the 3-month office follow-up. Long-term follow-up (mean, 38.3 months; range, 4-85 months) was obtained in 75% of cases. Recurrence was noted in only one patient (two eyelids [2%]).
CONCLUSIONS: Modified transconjunctival lower eyelid entropion repair is a time-efficient, safe, and efficacious technique. In contrast to a recent report using another transconjunctival technique, we found a relatively low rate of recurrence on extended follow-up.

Entities:  

Mesh:

Year:  2002        PMID: 12414424     DOI: 10.1016/s0161-6420(02)01259-9

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  2 in total

Review 1.  Involutional lower eyelid entropion: causative factors and therapeutic management.

Authors:  Peihsuan Lin; Yoshiyuki Kitaguchi; Jacqueline Mupas-Uy; Maria Suzanne Sabundayo; Yasuhiro Takahashi; Hirohiko Kakizaki
Journal:  Int Ophthalmol       Date:  2018-10-12       Impact factor: 2.031

2.  Posterior layer advancement of lower eyelid retractors with transcanthal canthopexy for involutional lower eyelid entropion.

Authors:  Y Ishida; Y Takahashi; H Kakizaki
Journal:  Eye (Lond)       Date:  2016-07-15       Impact factor: 3.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.